NRXS

Vorhandelsmarkt: 7.33 -0.18 -2.40%

Neuraxis Inc (NRXS)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Neuraxis Inc Stock (NRXS) Company Profile

Neuraxis Inc

Healthcare (1114)

Biotechnology (623)

(812) 689-0791

11550 North Meridian Street, Suite 325, Carmel

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NRXS's Discussions on Twitter

Compare NRXS vs VRTX, REGN, ALNY, ARGX, INSM

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NRXS Neuraxis Inc	7.51	84.02M	3.57M	-7.80M	-6.56M	-0.9703
VRTX Vertex Pharmaceuticals Inc	454.97	115.58B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	79.23B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	43.59B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	43.26B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	31.97B	606.42M	-1.28B	-997.58M	-6.403

Neuraxis Inc Aktie (NRXS) Neueste Nachrichten

Finanzdaten der Neuraxis Inc-Aktie (NRXS)

Neuraxis Inc (NRXS)

Neuraxis Inc Stock (NRXS) Company Profile

Compare NRXS vs VRTX, REGN, ALNY, ARGX, INSM

Neuraxis Inc Aktie (NRXS) Neueste Nachrichten

Treasury Yields: Should I trade or invest in NeurAxis Inc2026 Pullbacks & Capital Efficiency Focused Ideas - baoquankhu1.vn

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth - TradingView

NeurAxis Shares Rise After Q4 Results Driven by Robust Revenue Expansion - Bitget

If You Invested $1,000 in Neuraxis Inc (NRXS) - Stock Titan

Craig Hallum Increases NeurAxis (NASDAQ:NRXS) Price Target to $13.00 - Defense World

Dip Buying: Can NeurAxis Inc outperform under higher oil prices2026 Trading Recap & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Gainers Report: Can NeurAxis Inc expand its profit marginsEarnings Beat & AI Powered Market Entry Ideas - baoquankhu1.vn

Neuraxis, Inc.: Fundamental Analysis and Financial Ratings | NRXS | US64134X2018 - marketscreener.com

NeurAxis (NASDAQ:NRXS) Given New $13.00 Price Target at Craig Hallum - MarketBeat

NeurAxis Earnings Call: Reimbursement Wins Drive Next Phase - TipRanks

Earnings call transcript: NeurAxis Q4 2025 sees revenue growth, stock dips - Investing.com Australia

NeurAxis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

NeurAxis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

NRXS: FY2025 revenue rose 33% to $3.6M, with improved net loss and expanded market access - TradingView

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph

Neuraxis 10-K: $3.57M Revenue, $(7.80)M Net Loss - TradingView

NeurAxis says its pain-treatment device now reaches 100M insured lives - Stock Titan

Neuraxis (NRXS) expands IB-Stim GI neuromodulation, RED constipation device and IP moat - Stock Titan

Levels Update: Should I trade or invest in NeurAxis Inc2026 Top Gainers & Expert Curated Trade Ideas - baoquankhu1.vn

Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Argenx Se (ARGX) and Teladoc (TDOC) - The Globe and Mail

Aug Ideas: What is the implied volatility of NeurAxis Inc2026 Fed Impact & Reliable Volume Spike Trade Alerts - baoquankhu1.vn

NeurAxis, Inc. Hits New 52-Week High of $7.46, Up 141.44% - Markets Mojo

Breakout Zone: Is NeurAxis Inc impacted by rising ratesTrade Exit Report & Stock Portfolio Risk Control - baoquankhu1.vn

NeurAxis, Inc. Hits New 52-Week High at USD 7.34 - Markets Mojo

Neuraxis price target raised to $8 from $7 at Craig-Hallum - MSN

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026 - Sahm

Medical tech firm NeurAxis schedules March 19 call on 2025 results - Stock Titan

Stock List: Research Stocks from Around the World - GuruFocus

NeurAxis (NASDAQ:NRXS) Shares Up 0.7%Still a Buy? - MarketBeat

NeurAxis, Inc. Hits New 52-Week High of $6.35, Up 98.97% - Markets Mojo

Volume Recap: Can TTWO expand its profit marginsJuly 2025 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

How FlexShares iBoxx 3 Year Target stock trades in high volatilityMarket Activity Summary & Reliable Price Breakout Signals - Naître et grandir

Update Recap: Should you avoid OSCR stock right now2025 Macro Impact & Entry Point Confirmation Alerts - baoquankhu1.vn

Aug Highlights: Can NeurAxis Inc stock outperform in a bear marketJuly 2025 Final Week & Real-Time Chart Breakout Alerts - baoquankhu1.vn

Chronic Idiopathic Constipation Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | ABBVIE, Eisai Co, Anji Pharma, Yuhan, Renexxion Ireland - Barchart.com

AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI

00152 Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

NeurAxis, Inc. Hits New 52-Week High of $6.30, Up 115.75% - Markets Mojo

S32 Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

BPCF Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

NRXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Neuraxis (NRXS) awards 47,569 RSUs to senior executive Miranda - Stock Titan

P 500Share Buyback & Expert Approved Trade Ideas - mfd.ru

NRXS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Director at Neuraxis (NRXS) receives 21,598-share equity grant as compensation - Stock Titan

Neuraxis (NRXS) CEO granted 94,173 RSUs in three-year vesting award - Stock Titan

Director at Neuraxis (NRXS) receives 21,598-share stock grant as compensation - Stock Titan

SMN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

LINK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Finanzdaten der Neuraxis Inc-Aktie (NRXS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NRXS